Australia markets closed

Mustang Bio, Inc. (MBIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3701-0.0009 (-0.24%)
As of 11:36AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.85M
Enterprise value 109.39k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)31.26
Enterprise value/revenue -1.32k
Enterprise value/EBITDA -0.00

Trading information

Stock price history

Beta (5Y monthly) 1.54
52-week change 3-91.25%
S&P500 52-week change 321.23%
52-week high 38.1700
52-week low 30.3300
50-day moving average 31.0422
200-day moving average 32.1241

Share statistics

Avg vol (3-month) 3202.69k
Avg vol (10-day) 3364.04k
Shares outstanding 59.54M
Implied shares outstanding 610.39M
Float 86.43M
% held by insiders 122.77%
% held by institutions 110.10%
Shares short (28 Mar 2024) 4177.98k
Short ratio (28 Mar 2024) 40.54
Short % of float (28 Mar 2024) 42.37%
Short % of shares outstanding (28 Mar 2024) 41.71%
Shares short (prior month 29 Feb 2024) 441.87k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 304 Apr 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-57.56%
Return on equity (ttm)-222.44%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -48.87M
Net income avi to common (ttm)-51.6M
Diluted EPS (ttm)-6.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.23M
Total cash per share (mrq)0.6
Total debt (mrq)2.5M
Total debt/equity (mrq)2,030.89%
Current ratio (mrq)0.74
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-49.48M
Levered free cash flow (ttm)-33.04M